Evidence map›Paper›PMID 27877686›Full record

ArticleScience and technology of advanced materials2014

Mo polyoxometalate nanoparticles inhibit tumor growth and vascular endothelial growth factor induced angiogenesis.

Wenjing Zheng, Licong Yang, Ying Liu, Xiuying Qin, Yanhui Zhou, Yunshan Zhou, Jie Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science and technology of advanced materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 21 citations in OpenAlex.

  1. Polyoxometalates Impact as Anticancer Agents.International journal of molecular sciences · 2023
    Review
  2. Green synthesis of copper oxide nanoparticles using sinapic acid: an underpinning step towards antiangiogenic therapy for breast cancer.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2019
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wenjing ZhengDepartment of Chemistry, Jinan University, Guangzhou 510632, People's Republic of China.
Licong YangDepartment of Chemistry, Jinan University, Guangzhou 510632, People's Republic of China.
Ying LiuDepartment of Chemistry, Jinan University, Guangzhou 510632, People's Republic of China.
Xiuying QinDepartment of Chemistry, Jinan University, Guangzhou 510632, People's Republic of China.
Yanhui ZhouDepartment of Chemistry, Jinan University, Guangzhou 510632, People's Republic of China.
Yunshan ZhouState Key Laboratory of Chemical Resource Engineering, Institute of Science, Beijing University of Chemical Technology, Beijing 100029, People's Republic of China.
Jie LiuDepartment of Chemistry, Jinan University, Guangzhou 510632, People's Republic of China.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor growth depends on angiogenesis, which can furnish the oxygen and nutrients that proliferate tumor cells. Thus, blocking angiogenesis can be an effective strategy to inhibit tumor growth. In this work, three typical nanoparticles based on polyoxometalates (POMs) have been prepared; we investigated their capability as antitumor and anti-angiogenesis agents. We found that Mo POM nanoparticles, especially complex

Indexed as

angiogenesisanticancernanoparticlespolyoxometalates (POMs)VEGF

Identifiers

PMID27877686
PMCPMC5090531
OpenAlexW1976703640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.